Searchable abstracts of presentations at key conferences in endocrinology

ea0052p18 | (1) | UKINETS2017

Circulating Tumour Cells (CTCs) are associated with bone metastases in patients with Neuroendocrine Tumours (NET)

Rizzo Francesca Maria , Childs Alexa , Mandair Dalvinder , Khan Mohid S , Cives Mauro , Ensell Leah , Lowe Helen , Caplin Martyn E , Toumpanakis Christos , Meyer Tim

Background: Bone metastases have been described in up to 15% of patients with NETs and are associated with a worse clinical outcome. Here we investigate the role of CTCs as a marker of bone metastases in a large cohort of patients with gastroenteropancreatic NETs.Methods: To be eligible for the study, patients were required to be ≥ 18 years old, have histologically confirmed midgut or pancreatic NET (pNET) and metastatic disease measurable by RECIS...

ea0081ep819 | Pituitary and Neuroendocrinology | ECE2022

Demonstration of the effects of asprosin on the sense of smell in female rats with hidden cookie test

Dila Oz Zeynep , Zorlu Go khan , Tan Fatih , Avcu Gaye Go ksu , Kacar Emine , Yasar Abdullah , Serhatlioglu Ihsan , Kelestimur Haluk , Yilmaz Bayram

Purpose: Asprosin is a novel glucogenic adipokine produced by the fibrillin 1 (FBN1) gene that is generated and released by white adipose tissue during fasting. Asprosin hormone has been shown to improve the sense of smell in wild-type mice by activating the OLFR734 receptor and decreasing the time it takes for them to discover hidden food. The purpose of this study was to determine the effects of asprosin on the sense of smell in female rats through the use of a hidden cookie...

ea0087p2 | Poster Presentations | UKINETS2022

PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK

Khan Mohid , Davies Louise , Back Melissa , Shah Tahir , Pritchard Mark , Cook Kathryn , Hull Diana , McKane Gail , Day Melissa , Grandoulier Anne-Sophie , Higgs Kate

Introduction: LAN, a somatostatin analogue, is a common first-line treatment for NETs. LAN comes as a pre-filled, ready-to-use syringe, administered every 4 weeks. In the UK, patients may receive LAN at home. The aim of PREF-NET was to generate real-world evidence describing patient’s experience of LAN administered in homecare and hospital settings, and the associated impact of treatment setting on other areas of patients’ lives.Methods: PREF-N...

ea0090p243 | Thyroid | ECE2023

Amiodarone-Induced Thyroid Disorders Not Uncommon

Khan Alaina , Lowe Miriam , Hayat Maisha , Ahuja Sanjali , English Robert , Hamid Kedir , Saleem Muhammad , Mahamud Bashir , Mohamed Ayan , Ramachandran Kirtanya , Mohammed Mohammed , Mlawa Gideon

Introduction: Amiodarone is a highly effective drug, used for the treatment of arrhythmias. However, it can cause either hypothyroidism or thyrotoxicosis. It leads to alterations in thyroid gland function or thyroid hormone metabolism, due to its high iodine content. Amiodarone-induced hypothyroidism is common in countries with high iodine dietary intake, and Amiodarone-induced thyrotoxicosis is more prevalent in regions with low iodine dietary intake. A large amount of iodide...

ea0091oc6 | Oral Communications | SFEEU2023

A miraculous case of muscle weakness and bone pain: the jaw-dropping factor.

Abdel-Malek Mariana , Alameri Majid , Bhatia Kunwar , Khan Sairah , Mukhopadhyay Suchana , Eyeson Josiah , McDonnell Fiona , Behary Preeshilla , Cox Jeremy , Comninos Alexander

Case History: A 47 year-old female was referred to the Endocrine Bone Unit with worsening back, rib and leg pain associated with significantly reduced mobility. In the preceding year, she had repeatedly presented to healthcare providers with no clear neurological deficit, no fractures identified on X-Ray and normal MRI appearances of the whole spine. Aside from well-controlled asthma and gestational diabetes, she had no significant past medical, medication, social or family hi...

ea0068p10 | Abstracts | UKINETS2019

Type III gastric neuroendocrine neoplasms: moving towards less-extensive resections in selected cases?

Exarchou Klaire , Kameniarz Lukasz , Victor Alexandra , Khan Mohid , Srirajaskanthan Raj , Mandair Dalvinder , Ramage John , Caplin Martyn , Pritchard David Mark , Toumpanakis Christos

Background: Type III gastric neuroendocrine neoplasms (g-NEN) are usually lesions of higher grade and often associated with loco-regional and distant metastases. Guidelines recommend partial or total gastrectomy with local lymph node resection. Data for less-extensive resections are limited.Aim: To assess whether advanced endoscopic excision [Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)] or localized surgical approach (wed...

ea0068p24 | Abstracts | UKINETS2019

Improving diagnosis times as part of the transformation of the South Wales NET Service

Amin Kapish , Gruber Mei-Yin , Shayan-Arani Holleh , Taylor Rebecca , Powell Catherine , Cook Katherine , Benny Ankita , Ng Sheryl , Christian Adam , Khan Mohid S

Background: Transformation of the South Wales NET service in late 2017 introduced new specialised staff, gastroenterology-led clinics and MDTs with a particular emphasis on educating referring specialties on NETs. Data has shown patient experience, satisfaction rates, quality of life and gastrointestinal symptom scores have all improved. This study aims to describe findings from new NET service data for: referrals into the service, diagnosis times after symptoms, and initial s...

ea0065oc4.1 | Thyroid | SFEBES2019

A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy

Read Martin , Baker Katie , Fletcher Alice , Thornton Caitlin , Alshahrani Mohammed , Nieto Hannah , Khan Rashida , Webster Jamie , Haggie Peter , Verkman Alan , Alderwick Luke , Boelaert Kristien , Smith Vicki , McCabe Christopher

New targeted drug strategies are urgently needed to improve radioiodine uptake and efficiently ablate thyroid cancer cells thereby minimising the risk of recurrent disease. High-throughput screening (HTS) offers a promising approach to identify new candidate drugs that will induce sodium iodide symporter (NIS) function to promote iodide uptake. However, significant progress has been limited by a lack of thyroid cell-based assays amenable to HTS. Here, we constructed a thyroid ...

ea0065p239 | Metabolism and Obesity | SFEBES2019

Weight loss and change in obesity related comorbidities in patients undergoing laparoscopic adjustable gastric banding at UHCW between 2009 and 2012

Leca Bianca , Dimitriadis Georgios K , Khan Uzma , Abraham Jenny , Halder Louise , Shuttlewood Emma , Shah Neha , Barber Thomas M , Menon Vinod , Randeva Harpal S

Background: The Royal College of Physicians (RCP) called earlier this year for obesity to urgently be recognized as a disease, and warned that until this happens its prevalence is unlikely to be reduced. Obesity is associated with multiple comorbidities, including type 2 diabetes mellitus (T2DM), hypertension (HT), and dyslipidemia. Bariatric surgery (BS) produces dramatic weight loss, with improvement of obesity associated comorbidities and decrease of overall mortality.<...

ea0049ep291 | Calcium &amp; Vitamin D metabolism | ECE2017

Chronic hypoparathyroidism disease profile from 492 patients in the PARADIGHM™ natural history global registry

Clarke Bart L , Ing Steven , Khan Aliya , Mannstadt Michael , McDermott Michael , Piccolo Rebecca , Shanik Michael H. , Vokes Tamara J , Germak John

PARADIGHM™ is a global registry (NCT01922440) of patients diagnosed with hypoparathyroidism (HPT) ≥6 months regardless of aetiology and management. Routine medical care data were entered using electronic case report forms; the 36-item Short Form Health Survey was completed by patients. Baseline-recorded data are reported for 492 patients enrolled as of 1 December 2016 from 41 centres. At baseline, 78% were women, mean (S.D.) age was 49 (17)...